PL1969118T5 - Wyizolowane komórki macierzyste wątroby - Google Patents
Wyizolowane komórki macierzyste wątrobyInfo
- Publication number
- PL1969118T5 PL1969118T5 PL06819033T PL06819033T PL1969118T5 PL 1969118 T5 PL1969118 T5 PL 1969118T5 PL 06819033 T PL06819033 T PL 06819033T PL 06819033 T PL06819033 T PL 06819033T PL 1969118 T5 PL1969118 T5 PL 1969118T5
- Authority
- PL
- Poland
- Prior art keywords
- stem cells
- liver
- relates
- present
- progenitor stem
- Prior art date
Links
- 210000000130 stem cell Anatomy 0.000 title abstract 4
- 210000004185 liver Anatomy 0.000 title abstract 3
- 210000004027 cell Anatomy 0.000 abstract 2
- 238000002054 transplantation Methods 0.000 abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010019663 Hepatic failure Diseases 0.000 abstract 1
- 238000010171 animal model Methods 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000010224 hepatic metabolism Effects 0.000 abstract 1
- 208000007903 liver failure Diseases 0.000 abstract 1
- 231100000835 liver failure Toxicity 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 231100000027 toxicology Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5067—Liver cells
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05447286 | 2005-12-21 | ||
EP2006010014 | 2006-10-17 | ||
PCT/EP2006/012046 WO2007071339A1 (en) | 2005-12-21 | 2006-12-14 | Isolated liver stem cells |
EP06819033.9A EP1969118B2 (en) | 2005-12-21 | 2006-12-14 | Isolated liver stem cells |
Publications (2)
Publication Number | Publication Date |
---|---|
PL1969118T3 PL1969118T3 (pl) | 2011-07-29 |
PL1969118T5 true PL1969118T5 (pl) | 2015-06-30 |
Family
ID=37775557
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06819033T PL1969118T5 (pl) | 2005-12-21 | 2006-12-14 | Wyizolowane komórki macierzyste wątroby |
PL10192665T PL2281875T3 (pl) | 2005-12-21 | 2006-12-14 | Wyizolowane komórki macierzyste wątroby |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10192665T PL2281875T3 (pl) | 2005-12-21 | 2006-12-14 | Wyizolowane komórki macierzyste wątroby |
Country Status (13)
Country | Link |
---|---|
US (5) | US8673635B2 (pl) |
EP (2) | EP1969118B2 (pl) |
JP (1) | JP5250423B2 (pl) |
CN (1) | CN103989710B (pl) |
AT (1) | ATE498005T1 (pl) |
AU (1) | AU2006328988B2 (pl) |
CA (1) | CA2634510C (pl) |
DE (1) | DE602006020071D1 (pl) |
DK (2) | DK2281875T3 (pl) |
ES (1) | ES2672205T3 (pl) |
PL (2) | PL1969118T5 (pl) |
PT (1) | PT2281875T (pl) |
WO (1) | WO2007071339A1 (pl) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2672205T3 (es) * | 2005-12-21 | 2018-06-13 | Université Catholique de Louvain | Células madre hepáticas aisladas |
EP2179034A1 (en) * | 2007-07-20 | 2010-04-28 | Cellartis AB | A novel population of hepatocytes derived via definitive endoderm (de-hep) from human blastocysts stem cells |
WO2010090513A2 (en) | 2009-02-03 | 2010-08-12 | Koninklijke Nederlandse Akademie Van Wetenschappen | Culture medium for epithelial stem cells and organoids comprising said stem cells. |
EP2412800A1 (en) | 2010-07-29 | 2012-02-01 | Koninklijke Nederlandse Akademie van Wetenschappen | Liver organoid, uses thereof and culture method for obtaining them |
US9752124B2 (en) | 2009-02-03 | 2017-09-05 | Koninklijke Nederlandse Akademie Van Wetenschappen | Culture medium for epithelial stem cells and organoids comprising the stem cells |
US20130071365A1 (en) * | 2010-02-16 | 2013-03-21 | Kyushu University, National University Corporation | Induced hepatocytes |
WO2012005690A1 (en) * | 2010-07-07 | 2012-01-12 | Massachusetts Institute Of Technology | Methods of reconstituting human hepatocytes and human hematopoietic cells in non-human mammals |
JP6000950B2 (ja) * | 2010-08-12 | 2016-10-05 | アーベーアーゲー フェアヴァルトゥングス ゲーエムベーハーAbag Verwaltungs Gmbh | 肝細胞の特徴を有する細胞を産生するための方法並びに同方法により産生された細胞及びその使用 |
US20130302291A1 (en) | 2011-01-25 | 2013-11-14 | Universite Catholique De Louvain | Compositions and methods for cell transplantation |
WO2013110354A1 (en) | 2012-01-25 | 2013-08-01 | Université Catholique de Louvain | Compositions and methods for cell transplantation |
JP6095272B2 (ja) * | 2011-03-25 | 2017-03-15 | 国立大学法人京都大学 | 上皮系体性幹細胞の製造方法 |
EP2554176B1 (en) | 2011-08-04 | 2016-07-27 | ETHIANUM Betriebsgesellschaft mbH & Co. KG | Means for liver regeneration |
WO2013047720A1 (ja) * | 2011-09-30 | 2013-04-04 | 公立大学法人横浜市立大学 | 肝細胞の分化誘導方法、ヒト化肝臓キメラ非ヒト動物の作製方法 |
US20140162355A1 (en) * | 2012-12-07 | 2014-06-12 | Antria, Inc. | Formulations Containing and Kit for Using Adipose-Derived Stem Cells and Use Thereof |
ES2759228T3 (es) | 2013-07-05 | 2020-05-08 | Univ Catholique Louvain | Medio acondicionado de células madre de hígado de adultos y su uso en el tratamiento de trastornos del hígado |
US10172889B2 (en) * | 2013-08-28 | 2019-01-08 | Promethera Biosciences S.A./N.V. | Method for producing adult liver progenitor cells |
WO2016001839A1 (en) * | 2014-06-30 | 2016-01-07 | Stempeutics Research Pvt. Ltd. | Management of liver disease using pooled mesenchymal stromal cells |
JP2017530697A (ja) * | 2014-08-28 | 2017-10-19 | プロメセラ バイオサイエンシーズ エス.アー./エンヌ.フェー. | 成体肝前駆細胞を作製する方法 |
WO2016086132A1 (en) * | 2014-11-26 | 2016-06-02 | Accelerated Biosciences Corp. | Induced hepatocytes and uses thereof |
FR3035407B1 (fr) | 2015-04-23 | 2022-06-17 | Francais Du Sang Ets | Procede de conservation de cellules, tissus ou organes en hypothermie |
WO2016183231A1 (en) | 2015-05-12 | 2016-11-17 | Baker Group, LLP | Method and system for a bioartificial organ |
US10774312B2 (en) * | 2015-05-14 | 2020-09-15 | Advanced Cell Technology And Engineering Ltd. | Method for producing frozen mesenchymal cells and method for producing implantable therapeutic member |
CN108431209B (zh) * | 2015-06-12 | 2023-02-10 | 新加坡科技研究局 | 肝脏干细胞的衍生和成熟肝细胞类型及其用途 |
US10287543B2 (en) * | 2015-11-19 | 2019-05-14 | Miltenyi Biotec, Gmbh | Process and device for isolating cells from biological tissue |
JP7063624B2 (ja) * | 2016-01-08 | 2022-05-09 | エヴィア ライフ サイエンシズ インコーポレイテッド | 低分子化合物による成熟肝細胞からの肝幹/前駆細胞の作製方法 |
JP6704617B2 (ja) * | 2016-01-29 | 2020-06-03 | 北海道公立大学法人 札幌医科大学 | 小型肝細胞の継代培養方法 |
EP3414319A4 (en) | 2016-02-10 | 2019-08-28 | Wake Forest University Health Sciences | HEPATIC FIBROSIS MODEL SYSTEM AND METHOD FOR MANUFACTURING AND USING SAME |
MA45274A (fr) * | 2016-03-02 | 2019-01-09 | Univ Catholique Louvain | Préparations améliorées de cellules progénitrices hépatiques adultes |
JP2019516391A (ja) * | 2016-05-24 | 2019-06-20 | リ, アルバートLI, Albert | 新規な細胞培養方法、細胞培養システム、およびそれらの使用 |
US11976302B2 (en) | 2017-05-06 | 2024-05-07 | Upside Foods, Inc. | Compositions and methods for increasing the culture density of a cellular biomass within a cultivation infrastructure |
CA3064352A1 (en) | 2017-05-24 | 2018-11-29 | Thoeris Gmbh | Use of glutamine synthetase for treating hyperammonemia |
WO2019014652A1 (en) * | 2017-07-13 | 2019-01-17 | Memphis Meats, Inc. | COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF CELL CULTURES USED IN FOOD PRODUCTION |
US11407979B2 (en) | 2017-09-01 | 2022-08-09 | Colorado State University Research Foundation | Intermittent starvation techniques to prolong functional lifetime of liver cells in culture |
US20210015844A1 (en) | 2018-03-14 | 2021-01-21 | Beacon Medcare (Hk) Limited | Composition for purification of biofluids |
CN108823146A (zh) * | 2018-06-22 | 2018-11-16 | 安徽 | 一种肝脏干细胞制备和提取方法 |
TW202035682A (zh) | 2018-12-14 | 2020-10-01 | 比利時商普羅米修亞生物科技股份有限公司 | 表現hla-g之肝先驅細胞及取得包含該等細胞之此等細胞組成物之方法與其用途 |
TW202043463A (zh) | 2018-12-14 | 2020-12-01 | 比利時商普羅米修亞生物科技股份有限公司 | 包含表現hla-e之肝先驅細胞之細胞組成物 |
CN109735485B (zh) * | 2019-01-29 | 2021-04-16 | 深圳市拓普生物科技有限公司 | 人源化肝脏动物模型及其构建方法和应用 |
EP3947645A1 (en) | 2019-03-26 | 2022-02-09 | Promethera Therapeutics Sa | Adult liver progenitor cells for treating non-alcoholic fatty liver disease |
SG11202110476YA (en) | 2019-03-26 | 2021-10-28 | Promethera Therapeutics Sa | Adult liver progenitor cells for treating acute-on-chronic liver failure |
JP7284985B2 (ja) * | 2019-03-29 | 2023-06-01 | 国立大学法人 長崎大学 | 肝前駆細胞を含む細胞集団を製造する方法 |
EP3963049A1 (en) | 2019-04-30 | 2022-03-09 | Promethera Therapeutics Sa | Preparation of human allogeneic liver-derived progenitor cells |
JP2022530620A (ja) | 2019-04-30 | 2022-06-30 | プロメセラ セラピューティクス エスエイ | ヒト同種肝臓由来前駆細胞の調製 |
WO2021021612A1 (en) * | 2019-07-26 | 2021-02-04 | Ambys Medicines, Inc. | Methods and compositions for producing hepatocytes |
KR20220081368A (ko) | 2019-10-09 | 2022-06-15 | 셀라온 에스에이 | 혈관 과투과성을 특징으로 하는 장애에서 간 전구세포 또는 줄기세포, 이의 용해물 및/또는 조건화 배지의 사용 |
JP2023516484A (ja) | 2020-03-11 | 2023-04-19 | ビット バイオ リミテッド | 肝細胞作製方法 |
EP3881853A1 (en) | 2020-03-20 | 2021-09-22 | Promethera Therapeutics Sa | Human allogeneic liver-derived progenitor cells for use in the treatment of inflammatory and infectious lung diseases and systemic inflammation |
EP3929280A1 (en) | 2020-06-26 | 2021-12-29 | Medizinische Hochschule Hannover | Process for producing liver cells |
WO2023180122A1 (en) | 2022-03-24 | 2023-09-28 | Université Catholique de Louvain | Use of human allogenic liver-derived progenitor cells for treating and/or preventing cellular senescence |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2917998B2 (ja) * | 1988-02-05 | 1999-07-12 | ホワイトヘッド・インスティチュート・フォー・バイオメディカル・リサーチ | 修飾された肝細胞およびその用途 |
US6069005A (en) † | 1991-08-07 | 2000-05-30 | Albert Einstein College Of Medicine Of Yeshwa University | Hapatoblasts and method of isolating same |
WO1994008598A1 (en) | 1992-10-09 | 1994-04-28 | Advanced Tissue Sciences, Inc. | Liver reserve cells |
US5869243A (en) | 1996-03-05 | 1999-02-09 | Rhode Island Hospital | Immortalized hepatocytes |
DE69739497D1 (de) | 1996-10-01 | 2009-08-27 | Geron Corp | Menschlische Telomerase katalytische Untereinheit |
US6774120B1 (en) | 1999-06-01 | 2004-08-10 | Sarah Ferber | Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
US8778899B2 (en) * | 1999-06-01 | 2014-07-15 | Sarah Ferber | Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
EP1252293B1 (en) * | 2000-01-19 | 2012-10-03 | University Of North Carolina At Chapel Hill | Liver tissue source |
DE60221987T2 (de) * | 2001-06-22 | 2008-05-15 | Stemcells, Inc., Palo Alto | Le-zellen (liver engrafting cells), assays und verwendungen davon |
US6617152B2 (en) | 2001-09-04 | 2003-09-09 | Corning Inc | Method for creating a cell growth surface on a polymeric substrate |
WO2003033697A1 (en) * | 2001-10-18 | 2003-04-24 | Ixion Biotechnology, Inc. | Conversion of liver stem and progenitor cells to pancreatic functional cells |
EP1624898A1 (en) | 2003-05-12 | 2006-02-15 | Sarah Ferber | Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
US20050074876A1 (en) * | 2003-10-03 | 2005-04-07 | Inserm | Bipotential liver cell lines from wild-type mammalian liver tissue |
WO2005035738A1 (en) * | 2003-10-07 | 2005-04-21 | Biomaster Inc. | Cell differentiation of adipose-derived precursor cells |
WO2006126219A1 (en) * | 2005-05-26 | 2006-11-30 | Fresenius Medical Care Deutschland G.M.B.H. | Liver progenitor cells |
ES2672205T3 (es) * | 2005-12-21 | 2018-06-13 | Université Catholique de Louvain | Células madre hepáticas aisladas |
-
2006
- 2006-12-14 ES ES10192665.7T patent/ES2672205T3/es active Active
- 2006-12-14 AU AU2006328988A patent/AU2006328988B2/en active Active
- 2006-12-14 PT PT101926657T patent/PT2281875T/pt unknown
- 2006-12-14 AT AT06819033T patent/ATE498005T1/de not_active IP Right Cessation
- 2006-12-14 CN CN201410143665.8A patent/CN103989710B/zh active Active
- 2006-12-14 JP JP2008546208A patent/JP5250423B2/ja active Active
- 2006-12-14 DE DE602006020071T patent/DE602006020071D1/de active Active
- 2006-12-14 PL PL06819033T patent/PL1969118T5/pl unknown
- 2006-12-14 DK DK10192665.7T patent/DK2281875T3/en active
- 2006-12-14 PL PL10192665T patent/PL2281875T3/pl unknown
- 2006-12-14 EP EP06819033.9A patent/EP1969118B2/en active Active
- 2006-12-14 DK DK06819033.9T patent/DK1969118T4/en active
- 2006-12-14 WO PCT/EP2006/012046 patent/WO2007071339A1/en active Application Filing
- 2006-12-14 US US12/097,743 patent/US8673635B2/en active Active
- 2006-12-14 EP EP10192665.7A patent/EP2281875B1/en active Active
- 2006-12-14 CA CA2634510A patent/CA2634510C/en active Active
-
2014
- 2014-01-10 US US14/152,673 patent/US8778607B2/en not_active Expired - Fee Related
- 2014-06-03 US US14/294,886 patent/US9107910B2/en active Active
-
2015
- 2015-07-09 US US14/795,195 patent/US9775863B2/en active Active
-
2017
- 2017-08-25 US US15/686,729 patent/US9931360B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US8778607B2 (en) | 2014-07-15 |
US9775863B2 (en) | 2017-10-03 |
JP5250423B2 (ja) | 2013-07-31 |
PL2281875T3 (pl) | 2018-08-31 |
WO2007071339A1 (en) | 2007-06-28 |
JP2009520474A (ja) | 2009-05-28 |
PL1969118T3 (pl) | 2011-07-29 |
DK2281875T3 (en) | 2018-06-06 |
PT2281875T (pt) | 2018-06-11 |
US20170354687A1 (en) | 2017-12-14 |
EP2281875A1 (en) | 2011-02-09 |
CN103989710B (zh) | 2019-11-15 |
US20140127676A1 (en) | 2014-05-08 |
US20140286917A1 (en) | 2014-09-25 |
ATE498005T1 (de) | 2011-02-15 |
ES2672205T3 (es) | 2018-06-13 |
CA2634510C (en) | 2018-01-09 |
DE602006020071D1 (de) | 2011-03-24 |
US9107910B2 (en) | 2015-08-18 |
EP1969118A1 (en) | 2008-09-17 |
US9931360B2 (en) | 2018-04-03 |
AU2006328988A1 (en) | 2007-06-28 |
US20150306147A1 (en) | 2015-10-29 |
US20080311094A1 (en) | 2008-12-18 |
DK1969118T4 (en) | 2014-12-15 |
AU2006328988B2 (en) | 2012-08-02 |
CN103989710A (zh) | 2014-08-20 |
EP2281875B1 (en) | 2018-03-21 |
DK1969118T3 (da) | 2011-05-16 |
EP1969118B2 (en) | 2014-09-10 |
EP1969118B1 (en) | 2011-02-09 |
US8673635B2 (en) | 2014-03-18 |
CA2634510A1 (en) | 2007-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2281875T (pt) | Células estaminais isoladas do fígado | |
Thorgeirsson et al. | Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence | |
Sakaida et al. | Development of cell therapy using autologous bone marrow cells for liver cirrhosis | |
WO2007100692A3 (en) | Method of generating human retinal progenitors from embryonic stem cells | |
PL1888742T3 (pl) | Komórki progenitorowe wątroby | |
EP1857542A4 (en) | METHOD FOR IN VITRO AMPLIFICATION OF ADULT STEM CELLS | |
WO2010017562A3 (en) | Induced pluripotent stem cells | |
WO2011043591A3 (en) | Method for differentiation into retinal cells from stem cells | |
EP1302536A3 (en) | Embryonic stem cells and neural progenitor cells derived therefrom | |
WO2009021151A8 (en) | Isolation, characterization and propagation of germline stem cells | |
WO2011043592A3 (en) | Compositions for inducing differentiation into retinal cells from retinal progenitor cells or inducing proliferation of retinal cells comprising wnt signaling pathway activators | |
WO2006047743A8 (en) | Swine multipotent adult progenitor cells | |
RU2665364C2 (ru) | Улучшение органов для трансплантации | |
WO2007051625A3 (en) | Compositions and methods for producing pluripotent cells from adult testis | |
Bilodeau et al. | Limitations of recellularized biological scaffolds for human transplantation | |
Deng et al. | Hepatic progenitor cell represents a transitioning cell population between liver epithelium and stroma | |
Maepa et al. | Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseases | |
WO2006045105A3 (en) | Generation and differentiation of adult stem cell lines | |
WO2007056505A3 (en) | Systems and methods for selection and maintenance of homogeneous and pluripotent human embryonic stem cells | |
WO2012075462A3 (en) | Methods and compositions for treatment of muscular dystrophy | |
WO2013184193A3 (en) | Cancer stem cells and methods of using the same | |
Chen et al. | Regulation of heme oxygenase 1 expression by miR-27b with stem cell therapy for liver regeneration in rats | |
Lee et al. | Advances in liver organoids: model systems for liver disease | |
WO2005094162A3 (en) | Culture and use of cells that secrete liver secretory factors | |
WO2006105204A3 (en) | Compositions and their uses directed to thymus and activation-regulated chemokine (tarc) |